A new trading day began on Tuesday, with AIM ImmunoTech Inc (AMEX: AIM) stock price down -3.78% from the previous day of trading, before settling in for the closing price of $0.21. AIM’s price has ranged from $0.16 to $0.62 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 11.74% over the last five years. Meanwhile, its annual earnings per share averaged 50.00%. With a float of $59.62 million, this company’s outstanding shares have now reached $67.67 million.
The firm has a total of 26 workers. Let’s measure their productivity. In terms of profitability, gross margin is 20.0%, operating margin of -14687.89%, and the pretax margin is -12594.21%.
AIM ImmunoTech Inc (AIM) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of AIM ImmunoTech Inc is 11.89%, while institutional ownership is 13.35%. The most recent insider transaction that took place on Nov 21 ’24, was worth 4,240. In this transaction CEO & President of this company bought 20,000 shares at a rate of $0.21, taking the stock ownership to the 1,657,968 shares. Before that another transaction happened on Dec 19 ’24, when Company’s Director sold 4,580 for $0.19, making the entire transaction worth $884. This insider now owns 118,549 shares in total.
AIM ImmunoTech Inc (AIM) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 50.00% per share during the next fiscal year.
AIM ImmunoTech Inc (AMEX: AIM) Trading Performance Indicators
Here are AIM ImmunoTech Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.75. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 71.63.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.47, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.35 in one year’s time.
Technical Analysis of AIM ImmunoTech Inc (AIM)
Analysing the last 5-days average volume posted by the [AIM ImmunoTech Inc, AIM], we can find that recorded value of 1.15 million was better than the volume posted last year of 0.86 million. As of the previous 9 days, the stock’s Stochastic %D was 43.05%. Additionally, its Average True Range was 0.02.
During the past 100 days, AIM ImmunoTech Inc’s (AIM) raw stochastic average was set at 19.66%, which indicates a significant decrease from 24.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 69.21% in the past 14 days, which was lower than the 76.74% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2125, while its 200-day Moving Average is $0.3136. Now, the first resistance to watch is $0.2158. This is followed by the second major resistance level at $0.2304. The third major resistance level sits at $0.2433. If the price goes on to break the first support level at $0.1883, it is likely to go to the next support level at $0.1754. Now, if the price goes above the second support level, the third support stands at $0.1608.
AIM ImmunoTech Inc (AMEX: AIM) Key Stats
With a market capitalization of 13.61 million, the company has a total of 63,779K Shares Outstanding. Currently, annual sales are 200 K while annual income is -28,960 K. The company’s previous quarter sales were 40 K while its latest quarter income was -3,700 K.
